Home » Topics » BioWorld Science

BioWorld Science
RSS

Cubist meets primary endpoint in second phase III Cidecin trial

Oct. 16, 2001

Antitumor antibiotics discovered at MCRF in Streptomyces

Oct. 15, 2001

Inhibitors of CDKs useful as anticancer agents

Oct. 15, 2001

Selective dopamine D3 receptor antagonists identified by Pharmacia

Oct. 15, 2001

Two Japanese patents cover Otsuka's new hypoglycemic/hypolipidemic compounds

Oct. 15, 2001

New VLA-4 antagonists in the Kaken pipeline

Oct. 15, 2001

Neuroprotective aminoadamantane derivatives disclosed by Panorama

Oct. 15, 2001

FDA issues approvable letter for Symlin in type 1 and type 2 diabetes

Oct. 15, 2001

New clinical data show Multikine's ability to eliminate HPV-induced cervical dysplasia

Oct. 15, 2001

Peregrine's Cotara receives FDA fast track review status

Oct. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...